Strengthening marketing of ‘CARTISTEM’ by participating in numerous overseas academic conferences2013/12/09STEM CELL THERAPEUTIC
‘NEUROSTEM-AD’ the treatment for Alzheimer’s disease requested for phase 1.2a clinical trials2013/06/28STEM CELL THERAPEUTIC
Mechanism of treatment for cartilage regeneration using stem cells, the first in the world2013/06/23STEM CELL THERAPEUTIC
MEDIPOST conducts the first procedure using the stem cell agent, CARTISTEM.2013/06/17STEM CELL THERAPEUTIC
MEDIPOST Submits Application for Product Authorization Amendment to Add Ankle Indications for CARTISTEM®2023/12/27
MEDIPOST Selected for a Government-Supported R&D Project Worth KRW 13 billion, to be Used for Global Market Expansion Including the U.S.2023/10/04
MEDIPOST’s CARTISEM®, Umbilical Cord Blood-derived Stem Cell Transplant Surgery Clinical Study Results Published in SCI-Level Journal2023/05/02
MEDIPOST Treats First Subject with CARTISTEM® in Japan Phase 3 Clinical Trial, Accelerating Clinical Development efforts in Japan2023/01/16
MEDIPOST Enhances its Partnership with Canada’s OmniaBio in Collaboration for the CMDO Business of OmniaBio’s All-Around Cell and Gene Therapy.2022/12/01